Ivan Gergel is an experienced leader in the pharmaceutical and healthcare sectors, currently serving as Chairman of the Board of Directors at Corsair Pharma since September 2023, and holding board positions at Theranica Bio-Electronics Ltd., Butterfly Medical, Neuraptive Therapeutics, and previously at Neurotrope Inc. and Realm Therapeutics, among others. As Managing Partner and Chief Medical Officer at New Rhein Healthcare Investors since March 2018, Ivan Gergel has contributed significantly to the management and development of innovative healthcare solutions. Ivan Gergel's educational background includes an MBA from The Wharton School, an MRCPsych from the Royal College of Psychiatrists, and an MD from the University of London.
Org chart
Sign up to view 4 direct reports
Get started
Teams
This person is not in any teams